NCT07544654 2026-04-22
A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
Phase 3 Not yet recruiting
Boehringer Ingelheim
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Children's Oncology Group
Collaborative Group for Adrenocortical Carcinoma Treatment